Assessing the burden of respiratory disease in the UK.
This review explores the health and social burden of some of the main respiratory diseases (asthma, chronic obstructive pulmonary disease, cryptogenic fibrosing alveolitis, cystic fibrosis, lung cancer, mesothelioma, obstructive sleep apnoea and tuberculosis) in order to increase awareness of these diseases and highlight areas where improvements in care are required. The overall impact of respiratory diseases in the U.K. in terms of prevalence, mortality, morbidity and economic costs, with particular reference to secondary care has been considered and comparisons made with the rest of Europe where data are available. Respiratory diseases are responsible for a significant proportion of serious morbidity and premature death among the population of the U.K. and they will continue to present a growing challenge; special support is needed to tackle this burden.
Chung
F
F
Royal Brompton & Harefield NHS Trust, London, U.K. f.chung@ic.ac.uk
Barnes
N
N
Allen
M
M
Angus
R
R
Corris
P
P
Knox
A
A
Miles
J
J
Morice
A
A
O'Reilly
J
J
Richardson
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D001249:Asthma / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000453:epidemiology; D005060:Europe / Q000453:epidemiology; D005260:Female; D017048:Health Care Costs; D006801:Humans; D015994:Incidence; D008017:Life Expectancy; D008175:Lung Neoplasms / Q000453:epidemiology; D008297:Male; D008654:Mesothelioma / Q000453:epidemiology; D008875:Middle Aged; D010997:Pleural Neoplasms / Q000453:epidemiology; D029424:Pulmonary Disease, Chronic Obstructive / Q000453:epidemiology; D011658:Pulmonary Fibrosis / Q000453:epidemiology; D012140:Respiratory Tract Diseases / Q000191:economics / Q000453:epidemiology*; D012891:Sleep Apnea Syndromes / Q000453:epidemiology; D014397:Tuberculosis, Pulmonary / Q000453:epidemiology; D006113:United Kingdom / Q000453:epidemiology